Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 9, 2006, Pages 1448-1454

  Nezu, Saeko ^a   Tanaka, Atsushi ^b   Yasui, Hideaki ^a   Imamura, Makiko ^a   Nakajima, Hiroshi ^a   Ishida, Hitoshi ^a   Takahashi, Shin Ichi ^a  

^a KYORIN UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimitochondrial autoantibodies; Autoimmune hepatitis; Histological findings

Indexed keywords

MITOCHONDRION ANTIBODY;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT INJURY; BILIARY TRACT DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 33746629773     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04434.x     Document Type: Article

References (28)

1. Neuberger J. Primary biliary cirrhosis. Lancet 1997; 350: 875-9.
2. Gershwin M, Ansari A, Mackay I et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol. Rev. 2000; 174: 210-25.
3. Miyakawa H, Tanaka A, Kikuchi K et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243-8.
4. Krawitt E. Autoimmune hepatitis. N. Engl. J. Med. 1996; 334: 897-903.
5. Bach N, Thung S, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15: 572-7.
6. Vyberg M. The hepatitis-associated bile duct lesion. Liver 1993; 13: 289-301.
7. Johnson P, McFarlane I. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
8. Alvarez F, Berg P, Bianchi F et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 1999; 31: 929-8.
9. Czaja A, Carpenter H. Autoimmune hepatitis with incidental histologie features of bile duct injury. Hepatology 2001; 34: 659-65.
10. Czaja A. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998; 28: 360-5.
11. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274-8.
12. Reynoso-Paz S, Leung P, Van de Water J et al. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Hepatology 2000; 31: 24-9.
13. Kenny R, Czaja A, Ludwig J, Dickson E. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig. Dis. Sci. 1986; 31: 705-11.
14. Zurgil N, Konikoff F, Bakimer R, Slor H, Shoenfeld Y. Detection of antimitochondrial antibodies: characterization by enzyme immunoassay and immunoblotting. Autoimmunity 1989; 4: 289-97.
15. Chazouilleres O, Wendum D, Serfety L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998; 28: 296-301.
16. Lohse A, Meyer zum Buschenfelde K-H, Franz B, Kanzler S, Gerken G, Dienes H-P. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999; 29: 1078-84.
17. Provenzano G, Diquattro O, Craxi A et al. Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis. Gut 1993; 34: 544-8.
18. Czaja A, Carpenter H, Manns M. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastoenterology 1993; 105: 1522-8.
19. Kitami N, Komada T, Ishii H et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern. Med. 1995; 34: 496-501.
20. Talwalkar J, Keach J, Angulo P, Lindor K. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am. J. Gastroenterol. 2002; 97: 1191-7.
21. Invernizzi P, Crosignani A, Battezzati P et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 1997; 25: 1090-5.
22. Nakanuma Y, Harada K, Kaji K et al. Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies. Liver 1997; 17: 281-7.
23. Kaserer K, Exner M, Mosberger I, Penner E, Wrba F. Characterization of the inflammatory infiltrate in autoimmune cholangitis. A morphological and immunohistochemical study. Virchows Arch. 1998; 432: 217-22.
24. Kinoshita H, Omagari K, Whittingham S et al. Autoimmune cholangitis and primary biliary cirrhosis: an autoimmune enigma. Liver 1999; 19: 122-8.
25. Kim W, Poterucha J, Jorgensen R et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology 1997; 26: 22-6.
26. Tsuneyama K, Van de Water J, Van Thiel D et al. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis. Hepatology 1995; 22: 1440-6.
27. Ikuno N, Scealy M, Davies J et al. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display. Hepatology 2001; 34: 478-86.
28. Neuberger J, Thomson R. PBC and AMA: What is the connection? Hepatology 1999; 29: 271-6.